IART
Integra Lifesciences Holdings Corp

363
Mkt Cap
$1.2B
Volume
1.78M
52W High
$27.13
52W Low
$11.06
PE Ratio
-2.36
IART Fundamentals
Price
$11.87
Prev Close
$15.43
Open
$15.40
50D MA
$14.78
Beta
1.18
Avg. Volume
1.15M
EPS (Annual)
-$0.0902
P/B
1.16
Rev/Employee
$366,361.92
Loading...
Loading...
News
all
press releases
Integra (IART) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·2h ago
News Placeholder
More News
News Placeholder
Integra LifeSciences (IART) Q3 Earnings Beat Estimates
Integra (IART) delivered earnings and revenue surprises of +25.58% and -3.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4h ago
News Placeholder
Should You Continue to Hold Integra Stock in Your Portfolio Now?
IART shows strong demand in neurosurgery and Tissue Technologies but faces macro and liquidity challenges.
Zacks·1mo ago
News Placeholder
Compared to Estimates, Integra (IART) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Integra (IART) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·3mo ago
News Placeholder
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates
Integra (IART) delivered earnings and revenue surprises of +4.65% and +5.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
IART Stock May Rise on First Enrollment in AERA Pediatric Registry
Integra enrolls first pediatric patient in AERA registry to evaluate real-world use of its ETBD system and expand ENT market presence.
Zacks·4mo ago
News Placeholder
Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound?
Zacks·5mo ago
News Placeholder
Integra (IART) Up 2.3% Since Last Earnings Report: Can It Continue?
Zacks·5mo ago
News Placeholder
Is the Options Market Predicting a Spike in Integra LifeSciences Stock?
Zacks·5mo ago
News Placeholder
Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm
Kaskela Law LLC announces that it has commenced an investigation into Integra LifeSciences Holdings Corp. (NASDAQ: IART) (Integra) on behalf of the companys long-term shareholders...
Business Wire·1y ago

Latest IART News

View

Advertisement|Remove ads.

Advertisement|Remove ads.